Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease [Phase 2]
A Phase 2 study evaluating the safety and tolerability of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertensio…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
The Ludwig Boltzmann Institute for Lung Health is conducting a prospective and retrospective observational registry study in Austria on inte…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC [NA]
This clinical trial update describes a study on using artificial intelligence in a pulmonary fibrosis clinic, with the trial listed as not y…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: WTC Chest CT Imaging Archive
The WTC Chest CT Imaging Archive study (NCT03295279) is currently recruiting, sponsored by Icahn School of Medicine at Mount Sinai, with ind…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) [NA]
University of Washington completed Trial 2 of a hospital-based program to improve communication about serious illness; results have been pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-02-20Clinical Trial Update: CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating comprehensive phenotypic characterization of patients with scleroderma-associated interstitial lung disea…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 [Phase 4]
Phase 4 study evaluating nintedanib for slowing lung disease in patients with fibrotic or non-fibrotic interstitial lung disease related to …
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease [Phase 1, Phase 2]
This document describes an early-phase clinical trial (Phase 1/2) evaluating safety, tolerability, and preliminary efficacy of NCR101 in sub…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: The Role of Standardized Training in the Diagnosis of Interstitial Lung Disease by Transbronchial Lung Cryobiopsy [NA]
Recruitment is ongoing for a study evaluating standardized training to diagnose interstitial lung disease using transbronchial lung cryobiop…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Rehabilitation Counselling for Patients with Interstitial Lung Disease
This clinical trial update notes that the study 'Rehabilitation Counselling for Patients with Interstitial Lung Disease' is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Open-label Study With Bosentan in Interstitial Lung Disease [Phase 2, Phase 3]
Open-label Phase 2/3 study of bosentan in interstitial lung disease and systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot Trial [NA]
A completed randomized controlled pilot trial evaluating a specialist dietetic intervention in malnourished patients with fibrotic interstit…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Chronic COUGH Management in Interstitial Lung DisEase [NA]
Clinical trial update for NCT06782893, a study on chronic cough management in interstitial lung disease sponsored by Aveiro University, curr…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Continuous Versus Demand-Based Oxygen in Patients With Fibrotic Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease [NA]
A not-yet-recruiting clinical trial comparing continuous versus demand-based oxygen therapy in patients with fibrotic interstitial lung dise…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Skeletal Muscle Function in Interstitial Lung Disease [NA]
This ClinicalTrials.gov entry updates an ongoing University of British Columbia study on skeletal muscle function in interstitial lung disea…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease [NA]
A clinical trial is evaluating whether beetroot juice improves exercise performance in patients with fibrotic interstitial lung disease. The…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease [Phase 2]
A Phase 2 study evaluating abatacept for myositis-associated interstitial lung disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF [Phase 3]
Phase 3 clinical trial evaluating a selective JAK inhibitor for interstitial lung disease due to systemic disease and skin tightness in syst…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Goals of Care Conversations Study [NA]
This VA-sponsored clinical trial update describes a goals-of-care conversations study that is currently enrolling by invitation, including s…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest [NA]
Completed Johns Hopkins trial evaluating oxygen delivery strategies. The study compares administered oxygen with high-flow ambient air at re…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD [NA]
The clinical trial assessing continuous positive airway pressure therapy in patients with obstructive sleep apnea and interstitial lung dise…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases [NA]
A recruiting clinical trial evaluating home-based clinical management for interstitial lung disease with progressive fibrosing phenotype in …
-
CLINICAL_TRIALS approval · 2024-12-10Clinical Trial Update: An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities
Expanded access program to provide Nintedanib to patients with non-IPF interstitial lung disease who have no alternative treatment possibili…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Interleukin23 in Systemic Lupus [NA]
A clinical trial is recruiting at Sohag University to evaluate interleukin-23 in systemic lupus erythematosus with interstitial lung disease…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study). [Phase 2]
Phase 2 trial evaluating H01 in adults with pulmonary hypertension including interstitial lung disease. The study has completed and results …